Walter Sebald
#152,628
Most Influential Person Now
Walter Sebald's AcademicInfluence.com Rankings
Walter Sebaldbiology Degrees
Biology
#11527
World Rank
#14929
Historical Rank
Genetics
#1242
World Rank
#1343
Historical Rank
Molecular Biology
#1777
World Rank
#1806
Historical Rank
Neuroscience
#1873
World Rank
#1929
Historical Rank
Download Badge
Biology
Walter Sebald's Degrees
- Masters Biochemistry Stanford University
- Bachelors Biology University of California, Berkeley
Similar Degrees You Can Earn
Why Is Walter Sebald Influential?
(Suggest an Edit or Addition)Walter Sebald's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The Mode of Bone Morphogenetic Protein (BMP) Receptor Oligomerization Determines Different BMP-2 Signaling Pathways* (2002) (558)
- Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. (1996) (534)
- Crystal structure of human bone morphogenetic protein-2 at 2.7 A resolution. (1999) (337)
- Crystal structure of the BMP-2–BRIA ectodomain complex (2000) (311)
- Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors. (2000) (299)
- GENETICS AND BIOGENESIS OF CHLOROPLASTS AND MITOCHONDRIA (1976) (261)
- The triose phosphate‐3‐phosphoglycerate‐phosphate translocator from spinach chloroplasts: nucleotide sequence of a full‐length cDNA clone and import of the in vitro synthesized precursor protein into chloroplasts. (1989) (256)
- BMP‐2 antagonists emerge from alterations in the low‐affinity binding epitope for receptor BMPR‐II (2000) (249)
- Activating and deactivating mutations in the receptor interaction site of GDF5 cause symphalangism or brachydactyly type A2. (2005) (205)
- Molecular recognition of BMP-2 and BMP receptor IA (2004) (200)
- Mitochondrial genes and translation products. (1979) (198)
- Crystal Structure of the Interleukin-4/Receptor α Chain Complex Reveals a Mosaic Binding Interface (1999) (197)
- On the Structure and Genetics of the Proteolipid Subunit of the ATP Synthase Complex (1981) (197)
- Structure, binding, and antagonists in the IL-4/IL-13 receptor system. (2002) (189)
- The proton conducting F0-part of bacterial ATP synthases. (1984) (188)
- Adenoviral BMP-2 gene transfer in mesenchymal stem cells: in vitro and in vivo bone formation on biodegradable polymer scaffolds. (2002) (175)
- Conversion of human interleukin‐4 into a high affinity antagonist by a single amino acid replacement. (1992) (163)
- Mitochondrial porin of Neurospora crassa: cDNA cloning, in vitro expression and import into mitochondria. (1987) (150)
- Products of mitochondrial protein synthesis in Neurospora crassa. Determination of equimolar amounts of three products in cytochrome oxidase on the basis of amino-acid analysis. (1973) (148)
- Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction (2004) (147)
- A single residue of GDF-5 defines binding specificity to BMP receptor IB. (2005) (147)
- The imported preprotein of the proteolipid subunit of the mitochondrial ATP synthase from Neurospora crassa. Molecular cloning and sequencing of the mRNA. (1982) (143)
- A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor (2007) (141)
- p38 inhibitors prevent TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts. (2006) (132)
- The dicyclohexylcarbodiimide-binding protein of the mitochondrial ATPase complex from Neurospora crassa and Saccharomyces cerevisiae. Identification and isolation. (1979) (131)
- Human osteoprogenitor bone formation using encapsulated bone morphogenetic protein 2 in porous polymer scaffolds. (2004) (129)
- An antagonistic IL-4 mutant prevents type I allergy in the mouse: inhibition of the IL-4/IL-13 receptor system completely abrogates humoral immune response to allergen and development of allergic symptoms in vivo. (1998) (128)
- Two distinct functional sites of human interleukin 4 are identified by variants impaired in either receptor binding or receptor activation. (1993) (124)
- Nucleotide sequence and transcription of the fbc operon from Rhodopseudomonas sphaeroides. Evaluation of the deduced amino acid sequences of the FeS protein, cytochrome b and cytochrome c1. (1986) (121)
- Receptor oligomerization and beyond: a case study in bone morphogenetic proteins (2009) (120)
- Translational initiation frequency of atp genes from Escherichia coli: identification of an intercistronic sequence that enhances translation. (1985) (119)
- Processing peptidase of Neurospora mitochondria. Two-step cleavage of imported ATPase subunit 9. (1984) (118)
- Design of human interleukin-4 antagonists inhibiting interleukin-4-dependent and interleukin-13-dependent responses in T-cells and B-cells with high efficiency. (1994) (116)
- Initiation of Smad-Dependent and Smad-Independent Signaling via Distinct BMP-Receptor Complexes (2003) (115)
- Crossveinless 2 is an essential positive feedback regulator of Bmp signaling during zebrafish gastrulation (2006) (113)
- Crystal structure analysis reveals how the Chordin family member crossveinless 2 blocks BMP-2 receptor binding. (2008) (113)
- Enforced covalent trimerization increases the activity of the TNF ligand family members TRAIL and CD95L (2007) (110)
- Kinetics of antigen binding to antibody microspots: Strong limitation by mass transport to the surface (2006) (106)
- Modulation of GDF5/BRI‐b signalling through interaction with the tyrosine kinase receptor Ror2 (2004) (106)
- Interleukin-6 administration has no acute hemodynamic or hematologic effect in the dog. (1991) (106)
- N,N'-dicyclohexylcarbodiimide binds specifically to a single glutamyl residue of the proteolipid subunit of the mitochondrial adenosinetriphosphatases from Neurospora crassa and Saccharomyces cerevisiae. (1980) (104)
- Cycloheximide resistant incorporation of amino acids into a polypeptide of the cytochrome oxidase of Neurospora crassa. (1971) (101)
- Inductive properties of recombinant human BMP-2 produced in a bacterial expression system. (1998) (100)
- von Willebrand Factor Type C Domain-containing Proteins Regulate Bone Morphogenetic Protein Signaling through Different Recognition Mechanisms* (2007) (100)
- The primary structure of the iron-sulfur subunit of ubiquinol-cytochrome c reductase from Neurospora, determined by cDNA and gene sequencing. (1985) (97)
- Nucleotide sequence of the cloned mRNA and gene of the ADP/ATP carrier from Neurospora crassa. (1984) (95)
- Type I receptor binding of bone morphogenetic protein 6 is dependent on N‐glycosylation of the ligand (2008) (94)
- Mutations in GDF5 Reveal a Key Residue Mediating BMP Inhibition by NOGGIN (2009) (94)
- A mixed-charge pair in human interleukin 4 dominates high-affinity interaction with the receptor alpha chain. (1997) (92)
- Polyethylenimine-PEG coated albumin nanoparticles for BMP-2 delivery. (2010) (91)
- Intricacies of BMP receptor assembly. (2009) (88)
- Cooperativity of Binding Epitopes and Receptor Chains in the BMP/TGFß Superfamily (2001) (85)
- The Interleukin-4 Receptor Activates STAT5 by a Mechanism That Relies upon Common γ-Chain* (1998) (84)
- Type III TGF‐β receptor‐independent signalling of TGF‐β2 via TβRII‐B, an alternatively spliced TGF‐β type II receptor (2001) (83)
- Inhibition of the assembly of cytochrome oxidase in Neurospora crassa by chloramphenicol. (1972) (82)
- Radiation-induced impairment of bone healing can be overcome by recombinant human bone morphogenetic protein-2. (1998) (82)
- Bone morphogenetic protein 2 (BMP-2) induces sequential changes of Id gene expression in the breast cancer cell line MCF-7 (2000) (79)
- Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids (2007) (76)
- Biogenesis of mitochondrial ATPase. (1977) (74)
- Identification of two products of mitochondrial protein synthesis associated with mitochondrial adenosine triphosphatase from Neurospora crassa. (1975) (73)
- Global and Local Determinants for the Kinetics of Interleukin‐4/Interleukin‐4 Receptor α Chain Interaction (1996) (73)
- The proteolipid of a mutant ATPase from Escherichia coli defective in H+‐conduction contains a glycine instead of the carbodiimide‐reactive aspartyl residue (1980) (69)
- Inhibition of the IL-4/IL-13 receptor system prevents allergic sensitization without affecting established allergy in a mouse model for allergic asthma. (2003) (68)
- Osteoinductive capacity and heat stability of recombinant human bone morphogenetic protein-2 produced by Escherichia coli and dimerized by biochemical processing (2009) (68)
- Crystal structure analysis reveals a spring‐loaded latch as molecular mechanism for GDF‐5–type I receptor specificity (2009) (65)
- Identification of amino acid substitutions in the dicyclohexylcarbodiimide-binding subunit of the mitochondrial ATPase complex from oligomycin-resistant mutants of Saccharomyces cerevisiae. (1979) (64)
- In Vitro Osteogenic Response of Rat Bone Marrow Cells to bFGF and BMP-2 Treatments (2006) (64)
- Electrophoretic pattern of and amino acid incorporation in vitro into the insoluble mitochondrial protein of neurospora crassa wild type and mi‐1 mutant (1968) (63)
- Identification and Characterization of Genes for Polypeptides of the Thylakoid Membrane (1983) (62)
- Sustained Release Carriers Used to Delivery Bone Morphogenetic Proteins in the Bone Healing Process (2008) (62)
- The high-affinity interaction of human IL-4 and the receptor alpha chain is constituted by two independent binding clusters. (2002) (62)
- Isolation of recombinant BMP receptor IA ectodomain and its 2:1 complex with BMP‐2 (2000) (61)
- The dicyclohexylcarbodiimide‐binding protein of the mitochondrial ATPase complex from beef heart (1978) (61)
- RGD-grafted thermoreversible polymers to facilitate attachment of BMP-2 responsive C2C12 cells. (2005) (60)
- Identification of amino-acid substitutions in the proteolipid subunit of the ATP synthase from dicyclohexylcarbodiimide-resistant mutants of Escherichia coli. (1980) (60)
- The topology of the proton translocating F0 component of the ATP synthase from E. coli K12: studies with proteases. (1983) (59)
- Uniform RNA Patterns of Beet Necrotic Yellow Vein Virus in Sugarbeet Roots, but Not in Leaves from Several Plant Species (1986) (58)
- Amino acid sequence of a new mitochondrially synthesized proteolipid of the ATP synthase of Saccharomyces cerevisiae. (1984) (56)
- The Impact of the Route and Frequency of Antigen Exposure on the IgE Response in Allergy (2001) (55)
- Osteoinductive, morphologic, and biomechanical properties of autolyzed, antigen-extracted, allogeneic human bone. (1993) (54)
- Rational design of a GCN4-derived mimetic of interleukin-4 (1999) (53)
- Biological Chemistry of Organelle Formation (1980) (53)
- Mutant proteins of human interleukin 2. Renaturation yield, proliferative activity and receptor binding. (1989) (52)
- An Asp—Asn substitution in the proteolipid subnit of the ATP‐synthase from Escherichia coli leads to a non‐functional proton channel (1982) (52)
- A modular interface of IL-4 allows for scalable affinity without affecting specificity for the IL-4 receptor (2006) (52)
- Radiation-Induced Suppression of the Bmp2 Signal Transduction Pathway in the Pluripotent Mesenchymal Cell Line C2C12: An In Vitro Model for Prevention of Heterotopic Ossification by Radiotherapy (2003) (51)
- Structure Analysis of Bone Morphogenetic Protein-2 Type I Receptor Complexes Reveals a Mechanism of Receptor Inactivation in Juvenile Polyposis Syndrome* (2008) (51)
- Site‐directed mutagenesis reveals the importance of disulfide bridges and aromatic residues for structure and proliferative activity of human Interleukin‐4 (1991) (50)
- Different pool sizes of the precursor polypeptides of cytochrome oxidase from Neurospora crassa. (1972) (48)
- Enthalpic and entropic contributions mediate the role of disulfide bonds on the conformational stability of Interleukin‐4 (2006) (48)
- The interleukin‐4 site‐2 epitope determining binding of the common receptor γ chain (1998) (45)
- A Murine Interleukin-4 Antagonistic Mutant Protein Completely Inhibits Interleukin-4-induced Cell Proliferation, Differentiation, and Signal Transduction* (1997) (44)
- Amino Acid Sequence of the Putative Protonophore of the Energy-Transducing ATPase Complex (1978) (44)
- Activation of STAT5 by IL-4 relies on Janus kinase function but not on receptor tyrosine phosphorylation, and can contribute to both cell proliferation and gene regulation. (1999) (43)
- Nerve growth factor mediates activation of the Smad pathway in PC12 cells. (2004) (42)
- Cloning and expression of the fbc operon encoding the FeS protein, cytochrome b and cytochrome c1 from the Rhodopseudomonas sphaeroides b/c1 complex. (1985) (42)
- Enhancement of translational efficiency by the Escherichia coli atpE translational initiation region: its fusion with two human genes. (1986) (40)
- Incorporation of amino acids into mitochondrial protein of the flight muscle of Locusta migratoria in vitro and in vivo in the presence of cycloheximide (1969) (40)
- Time kinetics of bone defect healing in response to BMP-2 and GDF-5 characterised by in vivo biomechanics. (2011) (40)
- Global and local determinants for the kinetics of interleukin-4/interleukin-4 receptor alpha chain interaction. A biosensor study employing recombinant interleukin-4-binding protein. (1996) (38)
- GDF-5 can act as a context-dependent BMP-2 antagonist (2015) (38)
- Amino acid sequence of the proteolipid subunit of the proton-translocating ATPase complex from the thermophilic bacterium PS-3. (1980) (37)
- Localization and nucleotide sequence of the gene for the ATP synthase proteolipid subunit on the spinach plastid chromosome (1983) (37)
- Synthesis of a larger precursor for the proteolipid subunit of the mitochondrial ATPase complex of Neurospora crassa in a cell‐free wheat germ system (1979) (37)
- Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptor. (2001) (37)
- The interleukin-4 receptor activates STAT5 by a mechanism that relies upon common gamma-chain. (1998) (36)
- 18) Preparation of Neurospora crassa Mitochondria (1979) (36)
- Structure analysis of the IL-5 ligand-receptor complex reveals a wrench-like architecture for IL-5Rα. (2011) (36)
- Incorporation in vivo of 14C-labelled amino acids into the proteins of mitochondrial ribosomes from Neurospora crassa sensitive to cycloheximide and insensitive to Chloramphenicol. (1969) (35)
- Biochemical and Biophysical Characterization of RefoldedDrosophila DPP, a Homolog of Bone Morphogenetic Proteins 2 and 4* (1998) (35)
- The solution structure of BMPR-IA reveals a local disorder-to-order transition upon BMP-2 binding. (2008) (35)
- Bone repair in rat mandible by rhBMP-2 associated with two carriers. (2008) (35)
- Cycloheximide resistant amino acid incorporation into mitochondrial protein from Neurospora crassa in vivo (1969) (35)
- The interaction of BMP-7 and ActRII implicates a new mode of receptor assembly. (2003) (33)
- Gene expression profiling of connective tissue growth factor (CTGF) stimulated primary human tenon fibroblasts reveals an inflammatory and wound healing response in vitro (2011) (33)
- Diversity of the RNAs in Thirteen Isolates of Beet Necrotic Yellow Vein Virus in Chenopodium quinoa Detected by Means of Cloned cDNAs (1986) (33)
- Human IL-21 and IL-4 bind to partially overlapping epitopes of common γ-chain (2003) (32)
- Amino acid sequence of the proteolipid subunit of the ATP synthase from spinach chloroplasts (1980) (32)
- Aspects of receptor binding and signalling of interleukin-4 investigated by site-directed mutagenesis and NMR spectroscopy. (1994) (32)
- Site-specific PEGylation of bone morphogenetic protein-2 cysteine analogues. (2010) (31)
- The primary structure of cytochrome c1 from Neurospora crassa. (1987) (30)
- New insights into the molecular mechanism of multiple synostoses syndrome (SYNS): Mutation within the GDF5 knuckle epitope causes noggin‐resistance (2012) (29)
- Binding between Crossveinless-2 and Chordin Von Willebrand Factor Type C Domains Promotes BMP Signaling by Blocking Chordin Activity (2010) (29)
- Dimerization of signalling modules of the EvgAS and BvgAS phosphorelay systems. (2000) (29)
- L51P - A BMP2 variant with osteoinductive activity via inhibition of Noggin. (2012) (29)
- A strict requirement of interleukin‐4 for interleukin‐4 induction in antigen‐stimulated human memory T cells (1996) (28)
- Labeling of individual amino acid residues in the membrane-embedded F0 part of the F1 F0 ATP synthase from Neurospora crassa. Influence of oligomycin and dicyclohexylcarbodiimide. (1986) (28)
- The two subunits of the interleukin-4 receptor mediate independent and distinct patterns of ligand endocytosis. (1999) (27)
- Altered Amino Acid Sequence of the DCCD-binding Protein of the Nucelar, Oligomycin-resistant Mutant AP-2 From Neurospora crassa (1977) (27)
- Effect of recombinant human bone morphogenetic protein-2 on bone formation in the acute distraction osteogenesis of rat mandibles. (2009) (26)
- Functional epitope of common γ chain for interleukin-4 binding (2002) (26)
- Inhibition of endogenous antagonists with an engineered BMP-2 variant increases BMP-2 efficacy in rat femoral defect healing. (2012) (25)
- Puromycin sensitivity of ribosomal label after incorporation of 14C-labelled amino acids into isolated mitochondria from Neurospora crassa. (1969) (25)
- Bone healing process in critical-sized defects by rhBMP-2 using poloxamer gel and collagen sponge as carriers. (2008) (24)
- Preparation of Neurospora crassa mitochondria. (1979) (24)
- Upon Prolonged Allergen Exposure IL-4 and IL-4Rα Knockout Mice Produce Specific IgE Leading to Anaphylaxis (2001) (24)
- Topological studies suggest that the pathway of the protons through F0 is provided by amino acid residues accessible from the lipid phase. (1986) (23)
- Transmembrane and intracellular signalling by interleukin-4: receptor dimerization and beyond. (1996) (22)
- N-terminal specificity of PEGylation of human bone morphogenetic protein-2 at acidic pH. (2011) (22)
- Application of low-level laser irradiation (LLLI) and rhBMP-2 in critical bone defect of ovariectomized rats: histomorphometric evaluation. (2011) (21)
- A single administration of interleukin-4 antagonistic mutant DNA inhibits allergic airway inflammation in a mouse model of asthma (2003) (21)
- IL-4 receptor complexes containing or lacking the gamma C chain are inhibited by an overlapping set of antagonistic IL-4 mutant proteins. (1997) (21)
- [Comparison of the osteogenic activity of bone morphogenetic protein (BMP) mutants]. (2005) (21)
- INTERLEUKIN-4 / RECEPTOR ALPHA CHAIN COMPLEX (2000) (19)
- GENETICS AND BIOGENESIS OF CHLOROPLASTS AND (1976) (19)
- Neutralizing monoclonal antibodies define two different functional sites in human interleukin-4. (1994) (19)
- The human osteosarcoma cell line U‐2 OS expresses a 3.8 kilobase mRNA which codes for the sequence of the PDGF‐B chain (1986) (19)
- The binding of von Willebrand factor type C domains of Chordin family proteins to BMP-2 and Tsg is mediated by their SD1 subdomain. (2009) (18)
- Bone repair investigation using rhBMP‐2 and angiogenic protein extracted from latex (2012) (18)
- b-Type cytochromes. (1980) (17)
- Improving the refolding yield of interleukin-4 through the optimization of local interactions. (2000) (16)
- The interleukin-4 site-2 epitope determining binding of the common receptor gamma chain. (1998) (16)
- Influence of low‐level laser associated with osteogenic proteins recombinant human BMP‐2 and Hevea brasiliensis on bone repair in Wistar rats (2012) (15)
- Altered Amino Acid Sequence of the DCCD-binding Protein in the oli 1-resistant Mutant D 273-10 b/A 21 of Saccharomyces cerevisiae (1977) (15)
- The BMP2 antagonist inhibitor L51P enhances the osteogenic potential of BMP2 by simultaneous and delayed synergism. (2014) (14)
- Contribution of mitochondrial and cytoplasmic protein synthesis to the formation of cytochrome b and cytochrome aa3. (1973) (14)
- Immunological techniques for studies on the biogenesis of mitochondrial membrane proteins. (1981) (14)
- A Selection Fit Mechanism in BMP Receptor IA as a Possible Source for BMP Ligand-Receptor Promiscuity (2010) (12)
- Bone marrow cells from normal and ovariectomized rats respond differently to basic fibroblast growth factor and bone morphogenetic protein 2 treatment in vitro. (2005) (12)
- Functional epitope of common gamma chain for interleukin-4 binding. (2002) (12)
- Biological evaluation of the bone healing process after application of two potentially osteogenic proteins: an animal experimental model. (2012) (12)
- Antagonistic mutant proteins of interleukin-4. (1995) (11)
- Radiation-Induced Reduction of BMP-Induced Proteoglycan Synthesis in an Embryonal Mesenchymal Tissue Equivalent Using the Chicken “Limb Bud” Test (2001) (11)
- Topological and functional aspects of the proton conductor, F0, of theEscherichia coli ATP-synthase (1982) (11)
- [Evaluation of the osteoinductive potential of genetically modified BMP-2 variants]. (2004) (11)
- Isolation of a functional human interleukin 2 gene from a cosmid library by recombination in vivo. (1985) (11)
- Laser‐activated carbene labels the same residues in the proteolipid subunit of the ATP synthase in energized and nonenergized chloroplasts and mitochondria (1986) (11)
- Formation of mitochondria of locusta migratoria flight muscle (1971) (10)
- [Effect of different factors on the bone forming properties of recombinant BMPs]. (2000) (10)
- Antagonist design through forced electrostatic mismatch (1994) (10)
- Bone Recuperation After rhBMP-2 Insertion in Alcoholic Animals-Experimental Study. (2015) (10)
- Regeneration of Calvarial Defects with Escherichia coli-Derived rhBMP-2 Adsorbed in PLGA Membrane (2014) (10)
- [41] Mitochondrial ATPase complex from Neurospora crassa (1979) (10)
- A comparison of assays for the response of primary human T-cells upon stimulation with interleukin-2, interleukin-4 and interleukin-7. (1992) (10)
- The Clip-Segment of the von Willebrand Domain 1 of the BMP Modulator Protein Crossveinless 2 Is Preformed (2013) (10)
- Crystals of a 1:1 complex between human interleukin-4 and the extracellular domain of its receptor alpha chain. (1998) (9)
- Utilizing BMP-2 muteins for treatment of multiple myeloma (2017) (9)
- The BMP-2 mutant L51P: a BMP receptor IA binding-deficient inhibitor of noggin (2019) (9)
- IL-4 analogues with site-specific chemical modification at position 121 inhibit IL-4 and IL-13 biological activities. (2014) (9)
- Purification, crystallization and preliminary data analysis of ligand-receptor complexes of growth and differentiation factor 5 (GDF5) and BMP receptor IB (BRIB). (2009) (9)
- Regarding the mechanism of action of a proposed peptide agonist of the bone morphogenetic protein receptor activin-like kinase 3 (2013) (9)
- Human IL-21 and IL-4 bind to partially overlapping epitopes of common gamma-chain. (2003) (8)
- Biogenesis of mitochondrial membrane proteins in Neurospora crassa. (1979) (7)
- Enzymatic deglutathionylation to generate interleukin-4 cysteine muteins with free thiol. (2012) (7)
- IgG monoclonal antibodies that inhibit osteoinductivity of human bone matrix-derived proteins (hBMP/NCP). (1994) (6)
- Molecular basis of cytokine signalling – theme and variations (2010) (6)
- Inhibition of IL-4/IL-13 Does Not Enhance the Efficacy of Allergen Immunotherapy in Murine Allergic Airway Inflammation (2006) (5)
- Crystallization and preliminary X-ray diffraction analysis of human growth and differentiation factor 5 (GDF-5). (2005) (5)
- Mitochondrial ATPase complex from Neurospora crassa. (1979) (5)
- Renaturation yield, proliferative activity and receptor binding (1989) (5)
- [Mandibular reconstruction with autologous bone and osseoinductive implant in the Göttingen minipig]. (2004) (5)
- [The biological activity of E. coli-expressed BMP-4]. (1998) (5)
- Incorporation of Amino Acids into Mitochondrial Membrane Proteins (1969) (5)
- Deciphering the binding code of BMP-receptor interaction (2002) (4)
- Constitutive association of JAK1 and STAT5 in pro‐B cells is dissolved by interleukin‐4‐induced tyrosine phosphorylation of both proteins (1998) (4)
- Biological chemistry of organelle formation : 31. Colloquium der Gesellschaft für Biologische Chemie, 14.-19. April 1980 in Mosbach/Baden (1980) (4)
- Crystallization and preliminary X-ray analysis of the complex of the first von Willebrand type C domain bound to bone morphogenetic protein 2. (2008) (4)
- [Biological activity of E. coli expressed BMP-4]. (1998) (4)
- COOPERATION OF MITOCHONDRIAL AND CYTOPLASMIC PROTEIN SYNTHESIS IN THE FORMATION OF CYTOCHROME C OXIDASE (1974) (4)
- [EHBMP-2. Initial BMP analog with osteoinductive properties]. (1999) (3)
- Biological activity of a genetically modified BMP-2 variant with inhibitory activity (2009) (3)
- Molecular cloning of middle-abundant mRNAs from Neurospora crassa. (1983) (3)
- N '-Dicyclohexylcarbodiimide binds specifically to a single glutamyl residue of the proteolipid subunit of the mitochondrial adenosinetriphosphatases from Neurospora crassa and Saccharomyces cerevisiae ( inhibition of H + translocation / amino acid sequence / automated solid-phase Edman degradation (3)
- HUMAN BONE MORPHOGENETIC PROTEIN-2 (BMP-2) (1999) (3)
- Crystallization of BMP receptor type IA bound to the antibody Fab fragment AbD1556. (2010) (2)
- Purification, crystallization and preliminary data analysis of the ligand-receptor complex of the growth and differentiation factor 5 variant R57A (GDF5R57A) and BMP receptor IA (BRIA). (2011) (2)
- Resistance to TGF‐β1‐mediated growth inhibition correlates with sustained Smad2 phosphorylation in primary murine splenocytes (2002) (2)
- A two-step selection approach for the identification of ligand-binding determinants in cytokine receptors. (1999) (1)
- Mitochondrial porin of Neurospora crassa (1987) (1)
- Osteogenesis with BMP-2 variant L51P in a critical size defect model in rats (2010) (1)
- Proceedings: Identification of two products of mitochondrial protein synthesis associated with oligomycin-sensitive ATPase from Neurospora crassa. (1974) (1)
- New scaffolds for skeletal regeneration stimulating angiogenesis and osteogenesis (2006) (1)
- Type III TGF-b receptor-independent signalling of TGF-b 2 via T b RII-B , an alternatively spliced TGF-b type II receptor (1)
- Radio-induced membrane alteration as rationale of prevention of heterotopic ossification by radiotherapy: An in vitro study (2004) (0)
- COMPLEX BETWEEN BMP-2 AND TWO BMP RECEPTOR IA ECTODOMAINS (2000) (0)
- GDF-5 can act as a context-dependent BMP-2 antagonist (2015) (0)
- Determination of protein in conidia (1969) (0)
- Inductive properties of recombinant human BMP-2 produced in a bacterial expresston system Research; development (1998) (0)
- Does a Polypeptide Imported in Vitro Become Functional inside the Mitochondria ? (2013) (0)
- Interleukin-4 induces transcription of Hsp90a (1996) (0)
- The Dicyclohexylcarbodiimide-Binding Protein ofthe Mitochondrial ATPase Complex from Neurospora crassa (1979) (0)
- An antagonistic IL-4 mutant (QY) inhibits allergic symptoms mediated either by IgE or IgG dependent mast cell degranulation in vivo (1998) (0)
- IN VIVO HUMAN BONE FORMATION USING BMP-2 ENCAPSULATED POLYMER SCAFFOLDS (2005) (0)
- Contents Vol. 124, 2001 (2001) (0)
- Purification of cytochrome oxidase from Neurospora crassa and other sources. (1978) (0)
- [Cytochrome oxidase and associated with it a labelled protein from 14C-labelled mitochondria of Neurospora crassa]. (1969) (0)
- [Rapid labeling of a mitochondrially synthetized polypeptide of a cytochrome oxidase preparation from neurospora]. (1972) (0)
- Internal and external contributions to the biogenesis of mitochondrial proteins. (1970) (0)
- Crystal structure of a ternary ligand-receptor complex of BMP-2 (2007) (0)
- The Interleukin-4-Receptor: From Recognition Mechanism of Pharmacological Target Structure (2000) (0)
- of Allergic Symptoms In Vivo Immune Response to Allergen and Development Receptor System Completely Abrogates Humoral IL-4/IL-13 Allergy in the Mouse: Inhibition of the An Antagonistic IL-4 Mutant Prevents Type I (1998) (0)
- Table of Contents (1989) (0)
- IDENI'IFICATION AND CHARACI'ERIZATION OF GENES FOR roLYPEPI'IDES OF THE THYLAKOID MEMBRANE (1983) (0)
- Crystal structure of the interleukin-4 variant F82DR85A (2006) (0)
- Structure analysis of the ligand-receptor complex of bone morphogenetic protein 2 ( BMP-2 ) and its high-affinity receptor BMPR-IB (2004) (0)
- Effects of bone morphogenetic protein-2 on bone cells in primary culture : Immunohistochemical and electronmicroscopical studies (2001) (0)
- Structure of the bone morphogenetic protein 2 mutant L51P (2004) (0)
- Growth Factors in Tissue Engineering and Regenerative Medicine (2002) (0)
- Cloning and expression of the jbc operon encoding the FeS protein , cytochrome b and cytochrome c 1 from the Rhodopseudomonas sphaeroides b / c 1 complex (0)
- Modulation of GDF5/BRI-b signalling through interaction with the tyrosine kinase receptor Ror2 (2005) (0)
- Printed in Great Britain Topological and functional aspects of the proton conductor , F 0 , of the Bscherichia coli ATP-synthase (2011) (0)
- Crystal structure analysis of Bone Morphogenetic Protein-6 variant B2 (B2-BMP-6) (2008) (0)
- Armco Steel Corporation: Remarks (1955) (0)
- Crystal structure analysis of Bone Morphogenetic Protein-6 (BMP-6) (2008) (0)
- A highly efficient murine IL-4 antagonist as a model for rational drug design (1997) (0)
- The BMP-2:BMP receptor IA complex: structural evidence for type I/type II receptor discrimination (2000) (0)
- Isolation and manipulation of genes coding for energy-transducing enzymes from Neurospora crassa and Escherichia coli. (1984) (0)
- The modulation of the spontaneous and ongoing IgE synthesis of human PBMC by the partial antagonistic IL-4 mutant IL-4 (1994) (0)
- Crystal structure of the complex of BMP-2 and the first Von Willebrand domain type C of Crossveinless-2 (2008) (0)
- Cytokine antagonists and allergy. (1998) (0)
- Sex and Development in Mitochondria and Chloroplasts@@@Genetics and Biogenesis of Chloroplasts and Mitochondria. (1978) (0)
- On the structure and genetics of the proton-conducting F0 of the ATP synthase. (1984) (0)
- Crystal structure of wildtype human Interleukin-4 (2006) (0)
- Crystal structure of the neutralizing Fab fragment AbD1556 bound to the BMP type I receptor IA (2010) (0)
- Structure of a cytokine ligand-receptor complex (2012) (0)
- Crystal structure of human Growth and Differentiation Factor 5 (GDF-5) (2005) (0)
- Structural refinement of the complex of bone morphogenetic protein 2 and its type IA receptor (2004) (0)
- Osteoinduction by BMP-mutants (2005) (0)
- b-TYPE CYTOCHROMES1 (1980) (0)
- [Dependence of the structure of cytochrome oxidase on the presence of products from mitochondrial protein synthesis]. (1972) (0)
- Relevance of P38 in TGF–B–Induced Human Tenon Myofibroblast Transdifferentiation (2005) (0)
- Crystal structure of a TGF-beta ligand-receptor complex (2012) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Walter Sebald?
Walter Sebald is affiliated with the following schools:
